MCEFX | TRZPX | MCEFX / TRZPX | |
Total Expense Ratio | 1.90 | 0.00 | - |
Annual Report Gross Expense Ratio | 2.34 | 0.84 | 279% |
Fund Existence | 31 years | 5 years | - |
Gain YTD | 7.306 | 20.361 | 36% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 115M | 923M | 12% |
Annual Yield % from dividends | 1.87 | 3.09 | 61% |
Returns for 1 year | 2.57 | 8.65 | 30% |
Returns for 3 years | 58.72 | 60.90 | 96% |
Returns for 5 years | 37.03 | N/A | - |
Returns for 10 years | 45.40 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IVIAX | 24.80 | N/A | N/A |
Macquarie International Core Eq A | |||
PHPIX | 27.88 | N/A | N/A |
ProFunds Pharmaceuticals UltraSector Inv | |||
IVGSX | 19.55 | N/A | N/A |
VY® Invesco Growth and Income S | |||
MDGCX | 28.80 | N/A | N/A |
BlackRock Advantage Global Investor A | |||
RTNCX | 13.92 | -0.05 | -0.36% |
Russell Inv Tax-Managed Intl Eq C |